Monday, January 10, 2005
Medicinova Sets IPO Range
In more biotech-related IPO activity, San Diego-based Medicinova has set an estimated IPO range of $2.75 to $4.75 per share. The company is looking to raise up to $185M. Medicinova is developing pharmaceutical products for the urology and obstetrics/gynecology markets. The company had lost $44M on revenues of 354K in the nine months ending September 30, 2004, and has one product in Phase II and one Phase I clinical trials. The company's offering is being underwritten by Daiwa Securities.
Get More SocalTech Data
Try our two week free trial to find new tech customers, find high tech startups and jobs, find venture funding, and more!Learn More